Psychiatry Advisor3d
Long-Term Gantenerumab May Slow Decline in Dominantly Inherited Alzheimer Disease
For individuals with dominantly inherited Alzheimer disease (DIAD), long-term treatment with gantenerumab may delay clinical decline.
Early-onset Alzheimer’s: Drug shows promise in slowing the disease
Early-onset Alzheimer’s disease progresses more rapidly and often strikes people in the prime of their lives. A new treatment ...
Medical Xpress5d
Lancet Neurology
The Lancet is a weekly peer-reviewed general medical journal. It is one of the world s best known, oldest, and most respected general medical journals. The Lancet was founded in 1823 by Thomas ...
WashU could be paving path for delaying onset Alzheimer’s symptoms
Researchers at Washington University in St. Louis are making potential findings in delaying the onset of Alzheimer’s symptoms ...